BioPharma Dive7h
‘It’s not for the faint of heart.’ How 3 CEOs took their biotechs public
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Hosted on MSN23h
Aardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drug
Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.
Benchmarks Are Breaking Investment Management (And That's Our Opportunity)
How Goodhart’s Law Reveals the Opportunity in Long-Term Innovation Investing, and why traditional performance metrics may be ...
JD Supra7h
Trends in 2024 Securities Class Actions: AI and Biotech Cases On the Rise, Second Circuit Bounces Back
Cornerstone Research recently issued its 2024 Year in Review report examining recent trends in securities class action filings. For the second year ...
Swissinfo13h
Banking & Fintech
This content was published on Feb 14, 2025 Swiss National Bank defends negative interest rates as an important tool for taming the Swiss franc. This content was published on Feb 7, 2025 The ...
LIVE
Quality Power IPO Day 1 Highlights: Issue booked 62% so far. Check GMP trends, review, key dates, subscription status
Quality Power Electrical Equipments IPO price band is set at ₹401 to ₹425 per share. Subscription kicked off on February 14 and closes on February 18. Quality Power operates in the domain of energy ...
smallcaps7h
Savana Us Small Caps Active Etf (ASX: SVNP)
Get the latest market news, interviews and stock alerts. Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies. Small Caps and affiliated companies accept ...
smallcaps8h
Betashares S&P 500 Equal Weight Etf (ASX: QUS)
Get the latest market news, interviews and stock alerts. Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies. Small Caps and affiliated companies accept ...